Stocks · Health care · Pharmaceutical Preparations

BridgeBio Pharma, Inc.

BBIO Clue Score39
United States Fiscal year ends December CIK 0001743881 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Ali J. Satvat
30 Dec 2024
Director
Exercised, kept
39,851
$26.21
$1.04M
Ali J. Satvat
30 Dec 2024
Director
Exercised, kept
39,851
$16.68
$664.71K
Ali J. Satvat
30 Dec 2024
Director
Exercised, kept
79,702
$10.99
$875.92K
Showing 250 of 457 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 402
Amendments (4/A) skipped 5
Filings about a different issuer 8
Unreadable filings 0
Joint filings 12
Sales on a Rule 10b5-1 plan 212
Sales straight out of an exercise 73
Sales at will 146
Transactions with no price 1
Shares from compensation/vesting 141,557,600
Sales filed before the plan box existed 128
History held since 26 Jun 2018